To help expand clarify the biological need for this residue, we set up comprehensive Tyr296 mutants simply because fucosylated and nonfucosylated anti-CD20 IgG1s rituximab variants and examined their binding to recombinant soluble human Fc receptors: shFcRI, shFcRIIa, shFcRIIIa, and shFcRIIIb
To help expand clarify the biological need for this residue, we set up comprehensive Tyr296 mutants simply because fucosylated and…